With an increased confidence in the company’s prospects, HSBC raised its earnings estimates for Biocon, projecting ...

Biocon Ltd shares rose 4.7% after HSBC upgraded its rating to "buy" and raised the target price to Rs 430. The upgrade ...

Biocon's shares surged over 7% on January 14, 2025, after HSBC upgraded its rating to 'Buy' with a target price of ₹430, ...

London-based HSBC projects that the Philippines and other Southeast Asian countries will deliver robust economic growth this ...

According to reports, HSBC said that Biocon is well-placed for an operational turnaround, driven by key biosimilar launches ...

Brokerages have turned bullish over Biocon's growth prospects after the US FDA clearance of the drugmaker's Malaysia unit ...

HSBC expects an operational turnaround for Biocon, driven by major biosimilar launches and a rebound in generics sales. The ...

HSBC's base case target suggests 10 per cent upside over the prevailing stock price. Its bull case target suggests 40 per ...

27-25 in an hour and 11 minutes in the opening round of the HSBC BWF World Tour Super 750 event. In the paired events, Satwik ...

Hundreds of thousands of people travel across the causeway connecting Singapore and Malaysia daily, making it one of the ...

The stock has gained 9.66% in the last month, 7.99% over the past six months, and an impressive 37.98% in the last year.

Former champion PV Sindhu brushed off the rustiness of a long competition break to register a straight games win over Sung ...